Scientists from leading European research institutions, Goethe University Frankfurt, IRB Barcelona, AITHYRA in Vienna, the University of...

A recent article by Thorsten Mosler (Goethe University) in collaboration with researchers from Revvity Cellular Technologies (Sara...

Protein degraders, such as proteolysis-targeting chimeras (PROTACs) and other chimeric targeted protein degraders, represent a highly...

The Cluster4Future PROXIDRUGS and the innovation platform Futury GmbH have formed a strategic partnership with the aim of setting new...

On 8th of May 2025, the House of Pharma & Healthcare organised an exchange on the potential of pharmaceutical research at the University...

A new publication in the Journal of Medicinal Chemistry the PROXIDRUGS project leader Felix Hausch and his team from TU Darmstadt,...

On 22 April, the PROXIDRUGS Cluster4Future together with its partner House of Pharma & Healthcare hosted a public event on the Niederrad...

In their publication in Nature Chemical Biology PROXIDRUGS researchers and collaborating universities have discovered a way to prevent...

Since the beginning of this year, 22 partners from academic and industrial research are working collaboratively together in the 2nd...

The 4th Frankfurt Conference on Quality Control in Life Processes welcomed more than 300 speakers and attendees from all over the world....